A better understanding of the genetic codes of the Covid-19 virus, especially in vaccination studies, reaching 328 million cases
worldwide and still being 40% of community immunity, requires the normalization of vaccine and drug treatments by 60% of
community immunity and standardization of the outbreak. It is going to continue up to 40 months. The focus of our study, which
we will describe the Pse-in-One software, is to ensure that the correct vaccine is produced in vaccine studies. In the review of Liu et
al. published in a nucleic acid science journal in 2015 and Nature science journal in 2017, how this program became functional is
summarized in this study. I hope this article helps scientists in vaccine and drug development. I wish you good days.
On May 1, 2020, approved the number of cases in countries
nominal 1.1 million united states, 215 thousand Spain, 205 thousand
Italy, 177 thousand United Kingdoms, 163 thousand Germany, 130
thousand in France, 120 thousand Turkey, 114 thousand Russia,
and 95 thousand It is listed as Iran. Improving the numbers 133
thousand united states of America, Spain 115 thousand, 76
thousand Italy, Iran, 76 thousand, 118 thousand Germany, France
50 thousand, 48 thousand Turkey, Russia is ranked as 13 thousand.
If death rates of United States 64 thousand, 25 thousand Spain,
Italy, 28 thousand, 27 thousand united kingdoms, Germany 7
thousand, 24 thousand France, Turkey 3174 1200 Russia, Iran, and
six thousand [1]. Last Friday, India peaked with 2293 daily cases,
and in Mumbai, a woman tried to reduce the potential virus load in
her body by passing through the sterilization cabinet (Figure 1) [2].
Figure 1: A woman is passing through a sanitization tunnel in Mumbai, last week.
A private company in Calif produces 1.5 million vials sufficient
for 150000 patients. And the company in La Verne declared that
these bottles would be distributed free of charge (Figure 2) [2].
Beyond that, bus drivers in London began to refrain from driving
because of the increasing number of deaths in the country (Figure
3) [2].
Figure 2: Gilead Sciences in La Verne, Calif.
Figure 3: 28 bus drivers in 37 transportation workers in London died.
In Manila, 9731 detainees were released between March 1 and
April 29. Of these, 4600 were reported to have traveled to the Luzon
region, which includes the capital. This week, 212 people were
diagnosed with coronavirus in the Philippines, Cebu City (Figure 4)
[2].Here, the determination of coronavirus in urban wastes can be a
solution for taking precautions by knowing the onset of pandemics
early (Figure 5) [2].
Figure 4: Prisoners released in Manila.
Figure 5: Brazil’s National Institute of Science and Technology, the researcher collected sewage samples testing for
coronavirus last month.
The Pse-in-One version 2.0 was previously developed by Liu et
al. From the Pse-in-One version of the Pse-in-One version. It is a
web server and is more flexible than the first version. It contains
many component modes [3].This model has emerged today in
computational biology because of the difficulty of determining
sequences such as RNA, DNA, or protein for a biology unit. This
software is especially “Neural network,” “NN algorithm,” Supporting
vector machine,” and “SVM algorithm.” It also enables faster
resolution of difficulties encountered in existing machine learning
algorithms such as “Nearest Neighbor” because it is tough to think
of all these machine learning methods in a single learning method
[3].
Table 1: 6 new modes lists for DNA sequences.
Table 2: Eight new modes list for RNA sequences .
Table 3: Eight new modes list for protein sequences.
The entries related to Pse-in-one 2.0 software can be seen in
Tables 1-3. The algorithm of the program can be seen in Figure 4.
The results obtained by running the program are automatically
notified by e-mail [3].In the old version of the software, the sub
server can be seen in Figure 7 [4].
To improve the knowledge and interest of medical science,
the Pse-in-One 2.0 version presented in this article to obtain the
data needed by the researchers quickly and effectively in vaccine
development and drug discoveries.